0021 Effects of Pharmacological Estradiol Suppression on Urinary 6-sulfatoxymelatonin Output in Premenopausal Women
Shadab Rahman,Steven Lockley,Aviva Cohn,Hannah Kim,Aleta Wiley,Hadine Joffe,Leilah Grant
DOI: https://doi.org/10.1093/sleep/zsae067.0021
IF: 6.313
2024-04-20
SLEEP
Abstract:Abstract Introduction The relationship between the female sex steroid estradiol and the pineal hormone melatonin has been hypothesized to be reciprocal, whereby estradiol is low when melatonin is high and vice versa. Results from human studies have been mixed, however, which may be attributable to the large inter-individual differences in overall levels of melatonin secretion between individuals. Furthermore, menopause, characterized by declining levels of estradiol, has been associated with decreased levels of melatonin, although the contributions of ovarian aging versus chronological aging on melatonin levels is not clear. In the current within-subject experimental study of premenopausal women, we aimed to examine the effects of pharmacologically-induced estradiol suppression on the 24-hour output and circadian rhythm characteristics of the urinary melatonin metabolite, 6-sulfatoxymelatonin (aMT6s), thereby isolating estradiol-related effects from those if chronological aging. Methods Urine was collected every 3-4 hours during the daytime and 8-10 hours overnight over ~24 hours during a laboratory study from 12 premenopausal women (mean age±SD= 27.9±5.6 yrs) during their mid-to-late follicular phase when estradiol levels were high (i.e., estrogenized state), and again ~6 weeks later following pharmacologically-induced estradiol suppression (i.e., hypo-estrogenized state) due to administration of the gonadotrophin releasing hormone agonist, leuprolide (3.75mg intramuscular injection). Morning single-timepoint serum estradiol levels, 24-hour aMT6s output, and the cosinor analysis-derived mesor, amplitude and acrophase of the aMT6s rhythm were compared between the estradiol states using paired t-tests or non-parametric alternative. Results As expected, leuprolide suppressed estradiol levels by ~90% on average compared to levels in the mid-to-late follicular phase (p< 0.001; 120.7±43.4 vs. 5.6±0.6 pg/mL, respectively, Cohen’s d= 1.1). On average, 24-h aMT6s output was 5.3% higher following estradiol suppression but this was not significantly different from the estrogenized state (p=0.4; 16.1±5.7 vs. 15.4±1.6 μg/24-h, respectively, Cohen’s d= 0.12). Similarly, there were no differences in any of the aMT6s rhythm characteristics between estradiol states. Conclusion In a within-subject analysis, pharmacologically-induced estradiol suppression did not influence the overall 24-h output or rhythm characteristics of urinary 6-sulphatoxmelatonin, suggesting that that melatonin and estradiol may not be reciprocal. Furthermore, these results suggest that the decline in melatonin observed across menopause may not be due to ovarian aging. Support (if any) R01AG053838
neurosciences,clinical neurology